McKesson Corporation (MCK) has a MoatMap StockRank of 80/100 based on Quality (48/100), Value (57/100), and Momentum (58/100) factor scores. The current signal is BUY. McKesson is a high-quality pharmaceutical distributor with a massive economic moat, but it is not a direct beneficiary of our CDMO pricing power theme or other active macro tailwinds.
McKesson Corporation is a global leader in healthcare services, primarily operating as a major distributor of pharmaceuticals and medical supplies, alongside providing healthcare information technology solutions and pharmacy management services. The company's immense scale, sophisticated logistics network, and deep integration within the healthcare supply chain provide a substantial competitive moat, making it an indispensable partner for pharmaceutical manufacturers and healthcare providers. McKesson plays a critical role in delivering essential medicines and medical products efficiently across the globe.
| Price | $784.23 |
| Market Cap | $91.0B |
| P/E (TTM) | 19.72 |
| P/E (Forward) | 15.04 |
| Price/Book | -41.82 |
| Return on Invested Capital | 42.1% |
| Gross Margin | 3.6% |
| Operating Margin | 2.2% |
| Revenue Growth | 6.0% |
| Dividend Yield | 0.4% |
| Free Cash Flow | $5.7B |
McKesson Corporation operates in the Medical Distribution industry, part of the Healthcare sector (United States).